A pathological role of nuclear aggregates is supported by the effects of anti-aggregation therapies on improving OPMD phenotypes45, 62, and data showing that mutations in PABPN1 preventing aggregation do not lead to muscle pathology in Drosophila model63. Here, PABPN1 is linked to oculopharyngeal muscular dystrophy.